US 2010/0249205 A1 · Metabolites of Wortmannin Analogs and Methods of Using Same

Abstract

Novel metabolites of wortmannin and wortmannin analogs and their use in inhibiting PI-3 kinase activity in mammals and the treatment and prevention of cancer or tumor formation in a subject are described herein.

Claims4

Dependent claims

A compound selected from:

Dependencies are inferred from the claim text.

Facts

Application

12/752,935Filed 1 Apr 2010

Priority

30 Dec 2005

Published

30 Sep 2010

Term ends

Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07D 311/94
Ortho- or peri-condensed with carbocyclic rings or ring systems: condensed with rings other than six-membered or with ring systems containing such…
A61P 35/00
Antineoplastic agents
C07D
Heterocyclic compounds
A61P
Therapeutic uses of medicines

Family

Application60/755,477Us provisional application · filed 30 Dec 2005

Application11/618,036Continuation · filed 29 Dec 2006

Application12/752,935Continuation

US 2007/0191466 A1Published application

US 2010/0063129 A9Published application

US 7,723,375 B2Related patent

US 2010/0249205 A1This patent

From the US filing history. Foreign family members aren’t listed.

Metabolites of Wortmannin Analogs and Methods of Using Same

Life of this patent

Abstract

Claims4

Metabolites of Wortmannin Analogs and Methods of Using Same

Life of this patent

Abstract

Claims4